Cargando…
Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity
CONTEXT: Hypothalamic injury often leads to rapid, intractable weight gain causing hypothalamic obesity, which is associated with increased risk of cardiovascular and metabolic morbidity and mortality. There are no approved or effective pharmacological treatments for hypothalamic obesity, and conven...
Autores principales: | Huynh, Kim, Klose, Marianne, Krogsgaard, Kim, Drejer, Jørgen, Byberg, Sarah, Madsbad, Sten, Magkos, Faidon, Aharaz, Abdellatif, Edsberg, Berit, Tfelt-Hansen, Jacob, Astrup, Arne Vernon, Feldt-Rasmussen, Ulla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175551/ https://www.ncbi.nlm.nih.gov/pubmed/35294397 http://dx.doi.org/10.1530/EJE-21-0972 |
Ejemplares similares
-
Weight Loss, Improved Body Composition and Fat Distribution by Tesomet in Acquired Hypothalamic Obesity
por: Huynh, Kim D, et al.
Publicado: (2021) -
ODP350 Safety and Efficacy of Tesomet over 48 Weeks of Treatment: Results From a 24-Week Phase 2, Randomized, Double-Blind Study With 24 Week Open-Label Extension in Adults With Hypothalamic Obesity
por: Klose, Marianne, et al.
Publicado: (2022) -
Effects of Full-Fat and Fermented Dairy Products on Cardiometabolic Disease: Food Is More Than the Sum of Its Parts
por: Astrup, Arne, et al.
Publicado: (2019) -
Hypopituitarism in Traumatic Brain Injury—A Critical Note
por: Klose, Marianne, et al.
Publicado: (2015) -
Effects of Carbohydrate Restriction on Body Weight and Glycemic Control in Individuals with Type 2 Diabetes: A Randomized Controlled Trial of Efficacy in Real-Life Settings
por: Weber, Philip, et al.
Publicado: (2022)